| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.09 | 0.04 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.091 | 0.04 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.088 | 0.05 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.08 | 0.07 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.076 | 0.1 |